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Abstract
The study prepared a nanoemulsion with a diterpenoid isoprenoid 
alcohol called phytol (PYT) and subsequently tested it for antioxidant 
capacity. For this, PYT-loaded nanoemulsion was prepared by phase 
inversion method and both PYT-containing nanoemulsion (PNE) and 
PYT-free nanoemulsion (PFNE) (2-16 µM) were tested for antiradical 
activity (DPPH•: 1,1-dipheny-picrylhydrazyl radical; ABTS•+: azino-bis-
ethylbenzthiazoline-sulfonic acid; •OH: hydroxyl radical scavenging; 
NO•: nitrite oxide radical), lipid peroxidation (LP), reduction potential 
(RP), and inhibition of hemolysis (HL) in rat erythrocytes in compa-
rison with an α-tocopherol analogue (Trolox - TRO - positive con-
trol). In addition, an in vivo test was performed with wildtype and 
deficient Saccharomyces cerevisiae strains using hydrogen peroxide 
(H2O2) as a stressor. Results suggest that PNE exhibited higher anti-
oxidant than the PFNE. Increasing doses reveled antioxidant capacity 
in a dose-dependent manner. In the S. cerevisiae study, both PFNE- 
and PNE-treated groups exhibited decreased rates of survival with 
the highest doses, whichever in the presence of stressor increased 
the survival rates, which indicates antioxidative defense capacity of 
PYT. In this occasion, PNE exhibited prominent antioxidative defen-
se in the presence of stressor rather than PFNE. In conclusion, PYT 
exhibited potential antioxidant activity but at high concentration it 
was toxic to the yeast cells. The production of PYT-nanoemulsions 
may be relevant to the pharmaceutical sciences.
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Introduction 
Oxidative stress results from the reactive oxygen/
nitrogen species (ROS/RNS) and to the damage of 
essential macromolecules, with apoptosis or necro-
tic cell death. It is believed that the basic mechanism 
underlying toxicity may be extracellular reactive spe-
cies ultimately reaching the nucleus, where it causes 
DNA damage. Furthermore, DNA damage followed 
by subsequent cellular proliferation propagates 
errors and may result in carcinogenesis [1]. Although 
oxidative DNA damage is repaired by a number of 
different enzymes, some believe that oxidants and 
repair enzymes must remain at steady state [2].
Phytol (3, 7, 11, 15-tetrametilhexadec-2-en-1-ol; 
PYT), along with antioxidant, is already evident to 
have a number of biological activities, including an-
timicrobial, antispasmodic, antimutagenic, antibio-
tic-chemotherapeutic, anticancer, anti-teratogenic, 
antidiabetic, lipid lowering, anticonvulsant, immu-
noadjuvancy, antinociceptive, anti-inflammatory, 
anxiolytic, antidepressant, hair-fall defense and 
so on [3]. According to Andrade and Fasolo com-
pounds with antioxidant and antimicrobial activities 
may promote overall health [4]. PYT is still used as 
a fragrance material in a number of cosmetics and 
non-cosmetics products [3]. Nowadays extensive 
research is focusing on the natural products, espe-
cially derived from plants, despite of the synthesized 
medicaments. The use of natural antioxidant com-
pounds as a therapy in diseases related to oxidative 
stress has gained massive interest for their abilities 
to quench free radicals and the protection of the 
body against oxidative stress-induced pathogenesis. 
It is noteworthy that we have a number of synthetic 
antioxidants. Having high adverse effects and rela-
ted other unfavorable factors such as cost, availabi-
lity, safety and efficacy are the stimulation to search 
new compounds in this context. 
Otherwise, being an essential oil, PYT is a water 
non-soluble molecule, which limits its application 
and use in products for humans. So, we prepared 
PYT-loaded nanoemulsions (PNE), which along with 
the nanoemulsion-free PYT (PFNE) undergone to in-
vestigate the antioxidant capacity in a number of in 
vitro, ex vivo, and in vivo methods.
Materials and methods
Reagents and chemicals
Tween-80 (0.05%) dissolved in saline solution 
(0.9% NaCl) served as the vehicle. Trolox (6-Hydro-
xy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid; 
TRO) was used as the standard for all in vitro and 
ex vivo antioxidant assays. PYT, and all the neces-
sary reagents and chemicals used in this study were 
obtained from Sigma-Aldrich (St. Louis, MO, USA).
Preparation of PNE 
PNE was prepared by the emulsion phase inversion 
method. Briefly, an oil phase composed of medium 
chain triglycerides (1% w/w) and a surfactant (5% 
w/w) composed of soy phosphatidylcholine and so-
dium oleate (1:7 w/w) was slowly titrated with an 
aqueous solution of 2-methylpyrrolidone (2% w/v) 
at 70 °C under constant magnetic stirring (1,500 
rpm). This was emulsified using a basic Ultra-Turrax 
T18 equipped with the S 18 N-19 G dispersing tool 
at 11,000 rpm for one minute followed by four mi-
nutes at 7,000 rpm. The surfactant mixture that 
produced transparent colloidal dispersions was se-
lected in a previous study using a pseudo-ternary 
phase diagram [5].
Analysis of PYT-nanoparticles size distribution and 
zeta potential measurement
The mean droplet diameter of the nanoparticles 
was calculated using the cumulative method of 
analysis based on the intensity of the light scattered 
(DLS) in a particle size analyzer (Brookhaven Instru-
ments, USA) at 25 °C using a wavelength of 659 
nm and 90° detection angle. The correlation was 
performed in parallel mode and the data was analy-
zed using Zeta Plus® Particle Sizing version 3.95 
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software. Zeta potential (ZP) measurements were 
performed using the same equipment applying the 
same field strength (approximately 5.9 V/cm). Five 
runs for each sample were used to determine the ZP 
value using the PALS ZP Analyzer software and the 
electrophoretic mobility according the Helmholtz-
Smoluchowski equation. The samples were diluted 
1:100 (v/v) with purified water.
Drug loading into the nanoemulsions
The ability of the nanoemulsions to load PYT was 
tested by adding an excess of the drug into the oil 
phase before the emulsification step described abo-
ve. The samples were stored in a thermostatic bath 
at 25 °C and vortexed for one minute followed by 
15 minutes in an ultrasonic bath every 12 h for 72 h. 
After centrifugation (1000 x g for 15 minutes), the 
samples were filtered through an acetate membra-
ne (0.45 µm) and loaded PYT was analytically de-
termined by UV-Vis spectrophotometry at 239 nm 
using the equation from the fitted standard curve 
plot constructed previously.
Experimental animals 
The HL inhibition test was performed in eight week-
old Wister albino rats (Rattus norvegicus; body 
weight: 180-220 g) from the Central Animal House 
of the Federal University of Piaui, Brazil. The animals 
were allowed free access to food (Purina, Brazil) and 
tap water ad libitum and were kept under contro-
lled lighting (12 h dark/light cycles) at 24 ± 2 °C.
Test sample preparation
For the in vitro and ex vivo assays, PFNE and PNE 
were emulsified in 0.05% tween-80 dissolved in 
0.9% NaCl at final concentrations ranging from 
2-16 µM. Standard TRO was also dissolved in the 
same vehicle to give the same dilutions as PFNE and 
PNE. For the S. cerevisiae assay, PYT (PFNE and PNE) 
was adjusted to the same dose as above and in the 
same vehicle H2O2 (10 mM) was used as the stressor 
(STR) in this in vivo study. 
In vitro antioxidant activity assays
DPPH• scavenging activity
The test for DPPH• scavenging activity was done 
using a method slightly modified from that descri-
bed by Manzocco et al. [6]. Briefly, 0.3 mL samples 
with concentrations from 2-16 µM were added to 
a 2.7 mL ethanolic solution of DPPH (0.5 mM). 
After 30 min, the absorbance was measured using 
a spectrophotometer at 517 nm. A similar con-
centration of TRO served as the positive control, 
while only 0.3 mL vehicle was added to the DPPH 
solution for the negative control (NC). The blank 
contained no sample. The DPPH radical scaven-
ging potential was calculated using the following 
equation:
% inhibition of DPPH• scavenging = 
[(Abr – Aar)/Abr]×100
where Abr is the absorbance of DPPH free radicals 
before the reaction and Aar is the absorbance of 
DPPH free radicals after the reaction.
ABTS•+ decolorization activity 
The ABTS•+ decolorization assay was done as des-
cribed by Seeram et al. [7] with slight modification. 
ABTS•+ radicals were produced by adding solid 
manganese dioxide (80 mg) to a 5 mM aqueous 
stock solution of ABTS in 75 mM Na+/K+ buffer 
(pH 7.0). Then, 2.8 mL of the sample was added to 
0.2 mL of ABTS•+ solution. The absorbance was 
read at 750 nm after 5 minutes. The percentage of 
scavenging capacity was calculated as follows:
% ABTS•+ scavenged = [(Abr – Aar)/Abr]×100
where Abr is the absorbance of ABTS•+ free radi-
cals before the reaction and Aar is the absorbance 
of ABTS•+ free radicals after reaction with the test 
samples.
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•OH scavenging activity
The ability of test samples to scavenge hydrogen 
peroxide (H2O2) was determined according to the 
method described by Ruch et al. [8]. Briefly, a so-
lution of 40 mM H2O2 was prepared in phosphate 
buffer (50 mM; pH 7.4). The concentration of H2O2 
was measured spectrophotometrically by determi-
ning the absorption at 230 nm. The test samples 
(2–16 µM) and standards were added to the H2O2 
and the absorbance at 230 nm was determined 
after 10 minutes. A solution containing phosphate 
buffer without H2O2 served as the blank. The per-
centage of H2O2 scavenging was calculated using 
the following equation: 
% H2O2 scavenged = [(A0 – A)/A0]×100 
where A0 is the absorbance of the control and A is 
the absorbance of the test sample.
Nitric oxide (NO•) scavenging activity
To test for NO• scavenging activity, 0.375 mL of the 
test sample (PNE, FNE, and trolox), 1.5 mL of sodium 
nitroprusside (10 mM), and 0.375 mL phosphate bu-
ffer saline (PBS; pH 7.4) was mixed, and then the 
absorbance (Abr) was read at 546 nm. After incu-
bating the reaction mixture at 37 ˚C for 1 hour, 1 
mL of the solution was mixed with 1 mL Griess 
reagent. The reaction mixture was then incubated 
at room temperature for 30 minutes and the final 
absorbance (Aar) was measured at 546 nm. The 
negative control contained only 0.375 mL of the 
vehicle [9]. The amount of NO• inhibition was cal-
culated by the following equation:
% inhibition of NO radical = 
[(Abr – Aar)/Abr]×100
where Abr is the absorbance of NO• free radicals 
before the reaction and Aar is the absorbance of 
NO• free radicals after the reaction with the Griess 
reagent.
Lipid peroxidation inhibition activity
The TBARS (thiobarbituric acid radicals) assay was 
used to measure the quantity of lipid peroxidation 
activity. Briefly, 0.1 mL of sample (PFNE/PNE/TRO/
NC) was added to 1 mL homogenized egg yolk 
(1% w/v) in 20 mM phosphate buffer (pH 7.4). 
Lipid oxidation was induced by adding 0.1 mL of 
2,2'-azobis (2-methylpropionamidine) dihydrochlori-
de solution (AAPH; 0.12 M). The reaction mixture 
was incubated at 37 °C for 15 minutes. After coo-
ling, 0.5 mL of the sample was centrifuged after 
the addition of 0.5 mL of trichloroacetic acid (15%) 
at 1,200 × g for 10 minutes. An aliquot of 0.5 mL 
from the supernatant was mixed with 0.5 mL TBA 
(0.67%) and heated at 95 °C for 30 minutes. Af-
ter cooling, the absorbance was measured at 532 
nm using a spectrophotometer. The levels of lipid 
peroxides were expressed as nM of TBARS/mg egg 
yolk using an extinction coefficient of 1.56x105 mL/
cm. Finally, the results were expressed as the per-
centage of inhibition of lipid peroxidation [10]. 
Reduction potential (RP) capacity
The RP test was conducted using a method descri-
bed by Oyaizu [11] with the following modifications. 
A 0.2 mL sample was added to 0.5 mL of 0.2 M 
phosphate buffer (pH 6.6) and 0.5 mL of K3Fe(CN)6 
(1% w/v) and the reaction mixture was heated at 50 
˚C for 20 minutes. Then, 0.5 mL of trichloroacetic 
acid (10% w/v) was added with constant shaking, 
followed by the addition of 1.175 mL distilled water 
and 0.125 mL of FeCl3 (0.1% w/v) after 5 minutes. 
The absorbance of the sample was taken at 700 nm 
relative to a blank (without sample) For the NC, only 
0.2 mL of the vehicle was added and the samples 
were treated similarly. The reducing power capacity 
activity was calculated as follows:
Reducing potential (%) = [(Ats – Abs)/Ats]×100
where Ats is the absorbance of the test sample and 
Abs is the absorbance of the blank.
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Ex vivo antioxidant activity assay
HL inhibition capacity in rat erythrocytes
To test the inhibition of HL induced by H2O2, 
blood was collected from the retro-orbital plexus 
of anaesthetized (sodium pentobarbital 35 mg/kg; 
intraperitoneal) Wistar rats, and the erythrocytes 
were prepared for 10% suspension in PBS (pH 
7.4). Next, 0.15 mL hydrogen peroxide (200 mM 
in PBS; pH 7.4) and 0.2 mL of the sample solution 
were added to 0.5 mL of the 10% erythrocytes 
suspension. The reaction mixture was incubated at 
37 °C for 30 minutes and immediately centrifuged 
at 2,500 rpm for 3 minutes. Next, 0.2 mL of the 
supernatant was mixed with 2.8 mL PBS (pH 7.4) 
and the absorbance was measured at 475 nm [12]. 
For the NC, 0.2 mL of the vehicle was added. The 
percent rate of hemolysis was calculated using the 
following formula, taking into account that hemo-
lysis 100% was induced by H2O2 (blank): 
Inhibition of hemolysis (%) = 
[(Absblank – Abssample) x100] / Absblank
where Abs (blank) is the control absorbance with 
100% hemolysis induced by H2O2 and reactive Abs 
(sample) is the absorbance of aliquots containing 
various concentrations of the sample being studied. 
In vivo antioxidant activity
S. cerevisiae assay
Previously sub-cultured yeast strains were linearly 
swabbed onto sterile YEPD media (0.5% yeast ex-
tract, 2% peptone, 2% dextrose, and 2% bacte-
riological agar). Next, 0.01 mL of either a test sam-
ple or control were applied to sterile paper disks 
and treated accordingly. For sole and co-treated 
groups, the test samples (PFNE and PNE) and the 
samples plus STR were added, respectively. NC and 
STR groups were treated with sterile vehicle (0.05% 
tween-80 dissolved in 0.9% NaCl) or H2O2, res-
pectively. Treatments were done immediately after 
swabbing the organisms onto the petri dishes. The 
dishes were then inverted and kept in an incubator 
at 35 ± 1 °C for 72 h. The inhibition zones (in mm) 
were then measured. They ranged from 0 mm (full 
growth) to 40 mm (no growth), based on radius in 
the petri-dishes. All treatments were performed in 
duplicate [13]. 
Statistics 
Results are presented as the mean ± standard devia-
tion (SD). For in vitro and ex vivo antioxidant tests, 
data were analyzed by means of analysis of variance 
(one-way ANOVA) followed by t-Student-Newman-
Keuls's post-hoc test. For S. cerevisiae, one-way 
Bonferoni’s test and two Tukey post-tests were 
performed by using the GraphPadPrism software 
(version 6.0), considering p < 0.05.
Results and discussion
Preparation and characterization of PNE
Table 1 summarizes the physicochemical charac-
teristics of the transparent oil-in-water nanoemul-
sions successfully produced in the absence (VNE) or 
containing PNE. The colloidal dispersions exhibited 
small and uniformly distributed droplet sizes, with 
Table 1. Effect of PYT on droplet size (diameter), zeta potential (ZP) at VNE and drug loading at PNE.
Formulation code, composition 
(NMP, Mygliol®812, surfactant mixture, Phytol) Diameter (nm) ± SD PdI ZP (mV) ± SD Drug loading (%)
VNE, 0.2:0.1:0.5:0 130.2 ± 17.17 0.185 -108 ± 3.01 -
PNE, 0.2:0.1:05:0.10 245.5 ± 25.02 0.384 -77.8 ± 2.83 1.55
VNE: vehicle for nanoemulsion; PNE: phytol loaded nanoemulsion; PdI: diameter index for phytol
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VNE showing a mean diameter of 130.20 nm and 
polydispersity index (PdI) of 0.185. Drug loading 
caused the PNE droplet size to increase to a mean 
diameter of 245.50 nm (PdI = 0.384). Both VNE 
and PNE nanoemulsions showed large negative ZP 
values. The drug loading was calculated using the 
linear regression equation, A = 0.0045C + 0.005, 
which was extracted from the standard curve. The 
measured absorbance was substituted for "C", ex-
pressed as µg/mL (PYT). The correlation coefficient 
of the straight line was 0.9999. The maximum PYT 
loading on the oil-in-water (O/W) nanoemulsions 
was 1.55 ± 0.012% (n = 3), which allowed us to 
produce nanoemulsions containing 1% w/v (10 mg/
mL) PNE.
Nanoemulsions are commonly stabilized by rela-
tively large amounts of surfactant in order to pro-
duce transparent dispersions [14]. In this study, we 
have produced extraordinarily transparent nanoe-
mulsions with droplet sizes in the range of 130 to 
250 nm using low levels of surfactant (about 5% 
w/w). This was the result of using a suitable sur-
factant pair, composed of soy phosphatidylcholine 
and sodium oleate (1:7 w/w) associated with the 
co-solvent 2-methylpyrrolidone (2% w/v). The effect 
of surfactant composition [5] and co-solvent ratio 
[15] on both droplet size and droplet size distribu-
tion has been previously described. In addition, the 
composition of oil phase/surfactant/co-solvent used 
in this work produced stable nanoemulsions with 
high negative ZPs, guaranteeing suitable electros-
tatic resilience against flocculation. 
PYT loading contributed to the increased nanoe-
mulsion droplet size, which probably occurred due 
to PYT solubilizing in the oil phase. In previous stu-
dies with microemulsions containing the antitumor 
drug doxorubicin, we observed similar results, with 
drug loading increasing the droplet size of the mi-
croemulsions [16]. The same effect was also ob-
served for amphotericin B loaded oil-in-water mi-
croemulsions [17]. Thus, PYT is a liquid immiscible 
with water and, as observed with amphotericin B, 
its solubilization into oil phase contributes to increa-
sed droplet size. The mechanism of the latter case is 
not clear, but the ZP reduction observed for drug-
loaded nanoemulsions confirmed that PYT also dis-
rupts the surfactant film at the oil-water interface. 
It is possible that the drug is partially located in 
this region, which is important for PYT’s antioxidant 
effects.
Antioxidant activity assays 
Although living systems coexist with free radicals by 
developing diverse mechanisms for adapting them 
to advantageous physiological functions, excessive 
production of ROS and RNS are implicated in va-
rious diseases [18]. 
In vitro antioxidant activity assays
DPPH• scavenging activity
The DPPH• test is the most commonly performed 
assay for determining antioxidant activity by moni-
toring the decreased absorbance of the test sample. 
It assesses radical scavenging activity. Trolox, (+)-ca-
techin, ethyl gallate, ascorbic acid, and a-tocopherol 
are generally used as standards for screening new 
compounds [19]. Table 2 shows that PNE produced 
greater inhibitory effect when compared to PFNE 
for all four doses tested, but the activity was lower 
than the standard (TRO) treated with the same do-
ses. The highest inhibitions were observed for 16 
µM of PFNE, PNE, and TRO and were 50.44 ± 0.01, 
58.17 ± 0.01, and 76.59 ± 0.01%, respectively. The-
re was a dose-response relationship between the 
tested doses and inhibition.
ABTS•+ decolorization activity
The ABTS assay, which monitors the scavenging of 
ABTS•+ is another common method used to test for 
antioxidant activity. It is a peroxidase substrate upon 
oxidation in the presence of H2O2 that generates a 
metastable radical cation [19]. It confirms that there 
was improvement in the inhibition capability of PNE 
in comparison to TRO. The 16 µM dose of PNE, 
or TRO exhibited inhibition of 59.18 ± 0.01% and 
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Table 2. Antioxidant potential of PFNE/PNE in comparison to controls.
Samples
DPPH (% radical scavenge) ABTS (% radical scavenge) OH (% radical scavenge) NO (% radical scavenge)
PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO
16 (µM) 50.44 ± 0.01a 58.17 ± 0.01a 76.59 ± 0.01a 54.59 ± 0.01a 59.18 ± 0.01a 60.76 ± 0.01a 50.79 ± 0.01a 62.75 ± 0.02a 69.09 ± 0.02a 58.36 ± 0.01a,b 65.06 ± 0.01a 74.69 ± 0.02a
8 (µM) 43.63 ± 0.03a 34.34 ± 0.02a 67.40 ± 0.01a 40.03 ± 0.02a 39.24 ± 0.01a 49.58 ± 0.01a 35.93 ± 0.03a 36.18 ± 0.01a 48.75 ± 0.01a 32.81 ± 0.01a 37.11 ± 0.02a 48.18 ± 0.02a
4 (µM) 39.57 ± 0.01a 27.16 ± 0.01a 45.21 ± 0.01a 22.27 ± 0.01a 24.41 ± 0.02a 27.71 ± 0.02a 30.61 ± 0.01a 27.41 ± 0.01a 41.56 ± 0.01a 23.54 ± 0.01a 34.23 ± 0.01a 39.99 ± 0.01a
2 (µM) 31.06 ± 0.01a,b 19.49 ± 0.01a 26.17 ± 0.02a 15.73 ± 0.04a,b 16.06 ± 0.01a,b 10.36 ± 0.01a 21.64 ± 0.01a 15.82 ± 0.01a 22.66 ± 0.01a 12.85 ± 0.02a 8.93 ± 0.01a 36.56 ± 0.01a
NC 2.19 ± 0.05 1.29 ± 0.03 0.89 ± 0.02 1.01 ± 0.01
Samples
TBARS (% inhibition of lipid peroxidation) RP (% inhibition oxidation) HL (% inhibition hemolysis)
PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO
16 (µM) 66.89 ± 0.01a 74.52 ± 0.01a 95.02 ± 0.01a 64.13 ± 0.01a 87.34 ± 0.01a 94.09 ± 0.05a 58.85 ± 0.01a,b 43.82 ± 0.01a 65.81 ± 0.01a,b
8 (µM) 50.75 ± 0.01a 50.75 ± 0.01a 81.56 ± 0.01a 46.49 ± 0.01a 83.88 ± 0.01a 87.71 ± 0.02a 30.54 ± 0.01a 35.19 ± 0.01a 34.08 ± 0.01a,b
4 (µM) 38.89 ± 0.01a 38.89 ± 0.01a 65.86 ± 0.01a 38.89 ± 0.01a 77.82 ± 0.01a 83.19 ± 0.03a 22.91 ± 0.01a,b 19.37 ± 0.01a,b 16.76 ± 0.01a,b
2 (µM) 31.72 ± 0.01a,b 13.91 ± 0.01a 16.81 ± 0.01a 34.44 ± 0.01a 64.47 ± 0.01a 80.27 ± 0.05a 10.61 ± 0.01a,b 13.59 ± 0.01a,b 8.01 ± 0.01a,b
NC 2.11 ± 0.04 2.03 ± 0.02 1.07 ± 0.02
ap < 0.05 compared to NC (0.05% tween 80 in 0.9% NaCl); bp < 0.05, compared to TRO (ANOVA and t-Student-Newman-Kewls as post hoc test); 
PFNE: phytol free with nano-emulsion; PNE: phytol in nano-emulsion; TRO: trolox (standard); values are the mean ± SD (n = 5).
Table 3. IC50 of antioxidant potential of PYT and standard (trolox).
Parameters
DPPH test ABTS test OH test NO test
PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO
IC50 (mM/L) 1.39 ± 0.25 4.14 ± 0.53 3.14 ± 0.27 4.23 ± 0.47 4.50 ± 0.47 4.20 ± 0.24 2.76 ± 0.39 4.77 ± 0.55 3.26 ± 0.39 5.17 ± 0.58 4.76 ± 0.70 2.72 ± 0.51
CI 0.63-3.06 1.34-12.82 2.19-4.14 2.18-8.21 2.19-9.26 3.44-5.13 1.07-7.15 1.87-12.16 1.61-6.62 2.12-12.60 1.73-13.09 0.49-15.14
r2 0.96 0.85 0.98 0.94 0.93 0.99 0.89 0.89 0.93 0.90 0.88 0.75
Parameters
TBARS test RP test HL test
PFNE PNE TRO PFNE PNE TRO PFNE PNE TRO
IC50 (mM/L) 2.52 ± 0.38 4.22 ± 0.45 3.21 ± 0.58 2.08 ± 0.43 1.05 ± 0.12 0.41 ± 0.38 5.63 ± 0.66 3.81 ± 0.46 6.72 ± 0.76
CI 0.95-6.71 2.35-7.59 2.30-4.47 0.42-10.27 0.78-1.41 0.01-16.81 2.19-14.49 2.05-7.08 3.52-12.83
r2 0.89 0.95 0.98 0.82 0.99 0.84 0.89 0.94 0.94
IC50: inhibitory concentration 50% in µM; CI: confidence interval; r
2: coefficient of determination
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60.76 ± 0.01%, respectively (Table 2). There was 
also a dose-response relationship among the test 
samples. 
•OH scavenging activity
The free hydroxyl radical (•OH) generally reacts with 
polyunsaturated fatty acid moieties of cell mem-
brane phospholipids and causes cellular destruction 
[20]. Measuring the hydroxyl anionic radical (-•OH) 
is done similarly to the DPPH and ABTS assays, whe-
re •OH produced from the H2O2 is scavenged by 
the sample tested. We found that PNE, rather than 
PFNE, showed higher inhibition. The greatest inhi-
bition was observed for the highest dose (16 µM), 
resulting in 50.79 ± 0.01%, 62.75 ± 0.02%, and 
69.09 ± 0.02% by PFNE, PNE, and TRO, respec-
tively. The CI revealed that both PFNE (CI = 1.07-
7.15 µM; r2 = 0.89) and PNE (CI = 1.87-12.16 µM; 
r2 = 0.89) had improved activity in comparison to 
TRO (CI = 1.61-6.62 µM; r2 = 0.93; Table 3). There 
was also a dose-response relationship for the tested 
sample doses. 
Nitric oxide (NO•) scavenging activity
The sodium nitroprusside in the NO• scavenging 
test was used as the source of nitric oxide (NO) 
radical. Under aerobic conditions, NO reacts with 
oxygen to produce a stable nitrate (NO3•−) and ni-
trite (NO2•−) radicals, the quantities of which can 
be determined using the Griess reagent. In this test, 
PNE, rather than PFNE, had strong NO• scavenging 
activity, with an inhibition of 65.06 ± 0.01% by 
the 16 µM dose, while TRO by 74.69 ± 0.02%. 
However, increasing doses exhibited greater inhibi-
tion, thus indicating a dose-response relationship. 
The CIs for PFNE, PNE, and TRO were 2.12-12.60 
µM (r2 = 0.90), 1.73-13.09 µM (r2 = 0.88), and 0.49-
15.14 µM (r2 = 0.75), respectively (Table 3). Since 
PNE showed strong inhibition of NO• production, it 
could have physiologically important roles and could 
potentially prevent nitrosative stress [21]. 
Lipid per-oxidation inhibition activity
In the TBARS assay, lipid peroxidation was detec-
ted by measuring the amount of malonyl aldehyde 
(MDA) formed from unsaturated fatty acids. The 
more MDA that reacted with thiobarbituric acid 
(TBA), the stronger the pink coloration of the sam-
ple and the greater the absorbance [19]. Lipid pe-
roxidation is usually completed by AAPH (in vitro), 
but it was strongly inhibited by TRO, followed by 
PNE and PFNE. The CI parameter demonstrates the 
prominence activity of PNE with a coefficient of 0.95 
(r2) (Table 3). However, in this study, 16 µM of PNE 
and PFNE exhibited inhibition of LP by 74.52% and 
66.89% respectively. The oxidation/peroxidation of 
lipids by foreign chemicals is a major cause of liver 
injury [22]. In this in vitro test, the dose-response 
relationship and the significant (p < 0.05) inhibition 
of LP suggests PYT has potent antioxidant capacity. 
Reduction potential (RP) capacity
The RP assay is a rapid and sensitive antioxidant test, 
in which absorbance increases upon formation of a 
color complex with potassium ferricyanide, trichloro 
acetic acid, and ferric chloride. An increase in the 
absorbance indicates antioxidant activity of the test 
sample [23]. Antioxidants are the reducing agents. 
According to the Table 2, PNE improved the reduc-
tion activity more than PFNE for all of the doses 
tested. PFNE (16 µM) showed a similar reduction 
capability as the lowest dose of PNE (2 µM). The 
CI calculated for PFNE, PNE, and TRO were 0.42-
10.27 µM (r2 = 0.82), 0.78-1.41 µM (r2 = 0. 99), and 
0.01-16.81 µM (r2 = 0.84), respectively (Table 3). 
Even though the activity was lower than the TRO, 
there was a dose-response relationship in all cases. 
A possible simplified mechanism for the antioxidant 
activity of PYT is shown in Figure 1.
Ex vivo antioxidant activity assay
HL inhibition capacity in rat erythrocytes
Ex vivo HL was carried out by first treating rat 
erythrocytes with a lysis agent, H2O2. Then, HL in-
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hibition was assessed by measuring the hemoglo-
bin concentration in the reaction [12]. In this study, 
PFNE proficiently up-regulated erythrocyte mem-
brane stability and, thus, reduced HL. Erythrocyte 
lysis was decreased by 58.85 ± 0.01%, 43.82 ± 
0.01%, and 65.81 ± 0.01% after treatment with 16 
µM of PFNE, PNE, and TRO, respectively. Oxidative 
radicals, especially NO•, can bind to Fe2+-bound 
heme, which alters its physiological functions [24], 
since free hemoglobin (Hb) is crucial for dissolved 
oxygen (O2) and carbon-di-oxide (CO2) respiration 
during normal metabolic processes. Since PYT exhi-
bited strong NO• scavenging activity in this study, 
it may alter the detrimental in vivo effects of this 
radical. However, the lower inhibition of HL with 
PNE may be due to its greater hydrophobicity at 
high concentration and antioxidant-induced pro-
oxidative effects [25]. 
In vivo antioxidant activity
S. cerevisiae assay
Currently, there is evidence that the body prevents 
free radical damage [26] using some enzymes and 
substrates [27]. For example, the dismutation en-
zyme, superoxide dismutase (SOD), can convert 
Figure 1:  Simplified possible reducing mechanisms of phytol. (A: Free radical (neutralization) pathways. B: 
Ionization pathway).
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O2• into ordinary oxygen (O2) or H2O2. On the 
other hand, the catalase (CAT) enzyme, which is 
ubiquitous in most living organisms, is responsible 
for converting H2O2 to water (H2O) and oxygen 
(O2) [28]. These two enzymes are essential for the 
neutralization of ROS and keeping cells free from 
oxidative stress-mediated damage [29]. S. cerevi-
siae have antioxidant compounds in the cytoplasm, 
mitochondria, and on the entire surface of the cell 
[30]. In addition, one of its cell wall structural po-
lymers (1-3), (1-6)-b-D-glucan) has antioxidant [31] 
and immunomodulatory activities [32]. Therefore, 
this organism can be used to measure the anti-
oxidant action of a wide variety of organic and 
inorganic substances. In addition, this eukaryotic 
model allows for the investigation of the effects of 
antioxidants at the cellular level and is, thus, an at-
tractive alternative to mammalian cell lines. Based 
on colony formation tests performed by Bakkali et 
al. [25], certain EOs are cytotoxic to S. cerevisiae, 
mainly in the stationary growth phase. However, 
it depends on the state of cell growth as the cells 
in vegetative stage are much more sensitive due 
to high penetration power of EOs more efficiently 
at the budding sites. EOs containing phenolic, al-
dehyde, and alcoholic OH are cytotoxic in nature 
[33] and they may act against fungi [34]. 
Study-based conclusive talks
The use of PYT in aqueous dispersions requires a 
powerful solubilizing strategy, such as O/W nanoe-
mulsion. Previous studies have reported the efficacy 
of loading insoluble terpenes into nanoemulsions 
and the increased stability of these mixtures [35]. 
In addition, an antioxidant synergy formulation 
(ASF) containing delta, alpha, and gamma toco-
pherol loaded into nanoemulsions decreased in-
flammation in cD-1 mice, which was attributed to 
the increased bioavailability of gamma (2.2 folds) 
and delta (2.4 folds) tocopherol when compared 
to pure compounds [36]. The antioxidant activity of 
the anticancer compound quercetin was also increa-
sed when loaded into nanoemulsions, as measured 
as a function of prophylactic antitumor efficacy 
against DMBA-induced breast tumors [37]. It was 
also shown to combat doxorubicin- and cyclosporin 
A-induced cardiotoxicity and nephrotoxicity [38].
EOs are known for their antioxidant and cytotoxic, 
rather than mutagenic, activities. At low concentra-
tions, antioxidants cannot penetrate the mitochon-
drial membrane and, thus, may retain antioxidant, 
rather than cytotoxic or prooxidant, activities. Low 
concentrations of retinol and tocopherol exhibit an-
tioxidant and antimutagenic activities, whereas, at 
high concentration, they are genotoxic [39]. The-
refore, both the concentration of the antioxidant 
and the integrity of the mitochondrial membrane 
are keys for the antioxidant and cytotoxic activities 
of the EOs. 
Based on the results shown in Table 4, it is clear 
that PFNE had oxidative activities in Sod1∆Sod2∆ 
at all tested doses, but the inhibition zones (7.00-
11.00 mm) were lower than those seen for the STR 
(25.25 mm). The PFNE also exhibited an oxidative 
effect in the SOD-WT and Sod1∆ strains at 16 µM. 
Survival of the rest of the strains was significantly 
(p < 0.05) increased with the treated doses, where 
PFNE produced a statistical difference (p < 0.05) 
of 2 µM with 16 µM in SOD-WT, 2 µM and 4 µM 
with 16 µM in Sod1∆, 2 µM with 4 µM, 8 µM and 
16 µM in Sod2∆ and 2 µM with 16 µM in Cat1∆ 
strains, respectively. 
Table 5 shows that 2-16 µM PNE had an oxidative 
effect on the Sod1∆Sod2∆ and Sod1∆Cat1∆ stra-
ins, and 4-16 µM PNE had an effect in the Cat1∆ 
strain, but the inhibition zones were smaller when 
compared to STR. Only the 2 µM dose had an an-
tioxidative effect in Cat1∆ when compared to STR. 
In this case, 16 µM PNE also had oxidative activity in 
the SOD-WT strain. However, there was increased 
survival rates in the rest of the strains tested. The 
data presented here suggest no statistical differen-
ce between the doses of PNE tested. On the other 
hand, there was a difference in the results for PFNE 
and PNE treatments for the Cat1∆ and Sod1∆Cat1∆ 
strains. PFNE increased survival rates significantly (p 
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< 0.05), but PNE exhibited oxidative effects at all 
of the doses tested, except 2 µM. There may be an 
effect of the vehicle in which the PYT nanoparticles 
were emulsified. However, the data presented in 
both Tables 4 and 5 suggest lower zones of inhibi-
tion for both formulations, which were lower than 
the STR-treated group. The data shown in Tables 3 
and 4 reveal that both PYT formulations effectively 
protected all S. cerevisiae strains tested, thus de-
monstrating the antioxidant defense capacities of 
PFNE and PNE.
However, in the without-STR (nullified) treated 
groups and groups co-treated with 16 µM of PFNE/
PNE, the zones of inhibitions were slightly larger 
than for the other co-treated doses. There may be 
a hyperoxy effect; which was eventually minimized 
Table 4. IC50 of antioxidant potential of PYT and standard (trolox).
Parameters
Inhibition zones in millimeters in test strains
SOD-WT Sod1∆ Sod2∆ Cat1∆ Sod1∆Sod2∆ Sod1∆Cat1∆
NC (10 µL) 5.00 ± 1.24 5.50 ± 1.04 6.25 ± 0.73 6.75 ± 0.85 0.50 ± 0.33 0.25 ± 0.29
STR (10 mM) 20.25 ± 0.29a 24.50 ± 1.94a 24.00 ± 0.67a 24.00 ± 2.73a 25.25 ± 3.57a 12.75 ± 0.73a
Nullified STR
16 (µM) 7.75 ± 1.52a 10.75 ± 0.48a 10.25 ± 0.55 10.75 ± 0.86 11.00 ± 0.47a 8.75 ± 0.99
8 (µM) 6.50 ± 2.03 9.75 ± 0.48 9.75 ± 0.87 9.25 ± 0.76 8.75 ± 1.37a 7.75 ± 1.19
4 (µM) 7.50 ± 0.58 9.25 ± 0.63 9.25 ± 1.09 8.00 ± 0.56 8.75 ± 1.37a 7.00 ± 0.82
2 (µM) 5.00 ± 0.67 8.50 ± 0.29 8.50 ± 0.75 7.50 ± 0.74 8.50 ± 1.00a 5.50 ± 0.75
PFNE+STR
16 (µM) 10.25 ± 0.29a 13.25 ± 1.89a 7.75 ± 1.73b 6.50 ± 1.89b 8.50 ± 1.00a 8.75 ± 0.99b
8 (µM) 9.50 ± 0.33b 7.00 ± 1.68b 8.25 ± 0.85b 5.00 ± 1.58b 7.00 ± 0.82a 7.75 ± 1.19b
4 (µM) 9.50 ± 1.00b 5.50 ± 0.87b,c 7.50 ± 1.38b 7.50 ± 1.29b 9.00 ± 1.25a 7.00 ± 0.82b
2 (µM) 8.25 ± 0.73b,c 5.25 ± 0.75b,c 4.25 ± 0.73b,c,d,e 3.75 ± 0.46b,c 8.75 ± 1.28a 5.50 ± 0.75b
ap < 0.05 compared to NC (0.05% tween 80 in 0.9% NaCl); bp < 0.05 compared to STR (H2O2); cp < 0.05 compared to PFNE 14.16 µM; 
dp < 0.05 compared to PFNE 7.08 µM; ep < 0.05 compared to PFNE 4.72 µM (one-way ANOVA followed by Bonferoni’s test within 95% 
confidence interval); values are the mean ± SD (n = 4).
Table 5. Inhibition zones of PNE, NC and STR in proficient and mutant S. cerevisiae strains.
Parameters
Inhibition zones in millimeters in test strains
SOD-WT Sod1∆ Sod2∆ Cat1∆ Sod1∆Sod2∆ Sod1∆Cat1∆
NC (10 µL) 5.00 ± 1.24 5.50 ± 1.04 6.25 ± 0.73 6.75 ± 0.85 0.50 ± 0.33 0.25 ± 0.29
STR (10 mM) 20.25 ± 0.29a 24.50 ± 1.94a 24.00 ± 0.67a 24.00 ± 2.73a 25.25 ± 3.57a 12.75 ± 0.73a
Nullified STR
16 (µM) 9.25 ± 0.87a 10.00 ± 0.82 8.75 ± 1.09 8.25 ± 1.19a 10.25 ± 0.67a 9.50 ± 1.11a
8 (µM) 8.75 ± 0.87 8.50 ± 1.11 9.25 ± 0.55 8.75 ± 0.55a 9.50 ± 0.75a 9.25 ± 0.87a
4 (µM) 8.25 ± 0.55 7.00 ± 0.82 7.50 ± 1.00 8.25 ± 0.55a 8.00 ± 0.47a 8.25 ± 0.87a
2 (µM) 6.50 ± 0.75 6.25 ± 0.55 6.25 ± 0.55 6.50 ± 0.58a 6.25 ± 0.55a 7.00 ± 0.82a
PNE+STR
16 (µM) 9.75 ± 0.85a 6.25 ± 0.55b 7.75 ± 1.52b 6.75 ± 1.79a 8.25 ± 0.99a 7.75 ± 1.78a
8 (µM) 7.00 ± 1.70b 8.25 ± 1.28b 8.00 ± 1.25b 6.00 ± 1.83a 9.00 ± 0.94a 8.50 ± 1.38a
4 (µM) 8.00 ± 0.47b 7.50 ± 1.53b 8.25 ± 1.59b 8.25 ± 0.98a 6.25 ± 0.29a 7.75 ± 0.73a
2 (µM) 5.50 ± 0.33b 6.00 ± 1.06b 5.50 ± 0.75b 5.00 ± 0.82b 6.00 ± 0.67a 6.00 ± 1.06a
ap < 0.05 compared to NC (0.05% tween 80 in 0.9% NaCl); bp < 0.05 compared to STR (H2O2) (one-way ANOVA followed by Bonferoni’s test 
within 95% confidence interval); values are the mean ± SD (n = 4).
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after the application of STR encountered activity of 
both the PFNE and PNE. In the in vitro •OH scaven-
ging test (Table 2), PYT significantly (p < 0.05) aug-
mented •OH scavenging potential, thus the STR in 
this case produces OH radicals that may encounter 
PYT (PFNE/PNE). While the defense increased with 
decreasing doses of PFNE and PNE, the activity was 
significant (p < 0.05) when compared to the NC and 
STR-treated groups. 
It is clear that, like other aerobes, S. cerevisiae 
has a number of antioxidant defenses, such as: 
(i) a cytosolic copper-zinc superoxide dismutase 
(CuZn-SOD; Sod1) encoded by the SOD1 gene; (ii) 
a mitochondrial manganese superoxide dismutase 
(Mn-SOD; Sod2) encoded by the SOD2 gene; (iii) a 
cytosolic catalase encoded by the cTT1 gene; and 
(iv) a peroxisomal catalase encoded by the cTA1 
gene. However, S. cerevisiae can perform both ae-
robic and anaerobic metabolism depending on the 
nature of the carbon source. Under aerobic condi-
tions, S. cerevisiae produces energy mainly within 
its mitochondria using a process similar to that of 
human cells. According to Costa et al. [40], when 
wildtype S. cerevisiae is exposed to ethanol-ge-
nerating superoxide (O2•-) and H2O2 during both 
diauxic and post-diauxic growth and the mito-
chondrial Sod mutant (Sod2∆) produces essential 
protection against oxidative stress. A similar study 
was suggested while working on L-ascorbic acid 
by Saffi et al. [41]. In this study, both formulations 
of PYT protected the cytosolic Sod1∆, mitochon-
drial Sod2∆, and liver Cat1∆ mutants, which may 
confirm the potential protection against oxidative 
damage by PYT. 
Previous in vivo studies showed that 6, 12, 24, 
and 48 µM PYT had antioxidant activity in mice. It 
was also postulated to have significant •OH, O2•, 
methoxy radical (root CH2O•-), carbon-dioxide 
anion radical (CO2•), NO•, and DPPH• scavenging 
activities. There is also ex vivo evidence for the an-
tioxidant effects of PYT at doses of 2, 6, 12, and 
18 µM in Swiss mice [3]. 
There are compounds [42] (Nunes et al., 2014), 
including diterpene and carnosic acid (C20H28O4), 
that have antioxidant activity due to the presence 
of active -OH groups [43]. There are a number of 
commercially used natural antioxidants, including 
some diterpenes- kahweol, cafestol [44], carnosic 
acid, and carnosol [19], and oxidation products of 
carnosic acid (rosmanol and isorosmanol) [45]. On 
the other hand, there are also numerous natural 
antioxidants with reactive hydroxyl (–OH) groups, 
including carvacrol, thymol, euginol, isoeuginol, 
gereniol, caffeic acid, p-cumaric acid, terpein-4-ol, 
alpha-terpenol, limonen, and p-cymene [46].
PYT is a phenolic EO containing an OH group at 
its C1 position, which is of interest for its antioxi-
dant activity. In addition, an increased number of 
OH groups may increase the polarity of diterpenes. 
Recently, aldehyde, oxime, and ethyl bromocrotonyl 
derivatives of PYT have been shown to have 2, 4, 
and 6.5 folds more potent antitubercular activities, 
respectively [47], thus featuring a better pharmaco-
logical profile with synthetic products of PYT. 
Plant-based antioxidants (natural) have recently 
gained popularity due to their role as dietary supple-
ments with minimal side effects. There is no doubt 
that earlier researches done on PYT are demons-
trating its potential antioxidant capacity. Our study 
is also connecting the earlier reports on this diter-
pene. Both pure phytol (PFNE) and phytol-loaded 
nanoemulsions (PNE) in this study exhibited potent 
antioxidant activities in in vitro, ex vivo, and in vivo 
assays. In addition, the application of PNE as an 
innovative nanocarrier with a considerable soluble 
fraction of the studied terpene in chemical, food, 
and pharmaceutical industries have been well de-
monstrated. Nevertheless, earlier information about 
antioxidant potentials of PYT regarding its antira-
dical capacity is available for researchers. Results 
emerging from this study will substantially improve 
the advances in further non-clinical and clinical set-
tings for a wide range of illnesses related to oxi-
dative stress. Furthermore, PYT in nanopreparation 
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(PNE) exhibited better antioxidant activities than its 
free form (PFNE), which may suggest that emulsion 
preparation is possible by taking into pharmaceuti-
cals consideration.
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